OCULAR THERAPEUTIX, INC (OCUL) Free cash flow 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$216.9MFY2025 · since FY2016: -$35.9M → -$216.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$216.9M | -59.5% |
| FY2024 | -$136.0M | -78.1% |
| FY2023 | -$76.3M | -20.5% |
| FY2022 | -$63.3M | +5.1% |
| FY2021 | -$66.7M | -22.7% |
| FY2020 | -$54.4M | +31.8% |
| FY2019 | -$79.8M | -56.1% |
| FY2018 | -$51.1M | +13.0% |
| FY2017 | -$58.7M | -63.5% |
| FY2016 | -$35.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice